1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Joseph Alejandre made an unannounced visit to deliver the findings of the complaint investigation into the allegation listed above. LPA met with Administrator Rose Enriquez and explained the reason for the visit.
The investigation into the allegation, staff did not administer medication to resident as prescribed, revealed the following. Resident 1 (R1) moved into the facility on July 3,2024 and moved out of the facility on October 31, 2024. A review of R1's Medication Administration Record (MAR) for July, August, September and October 2024 shows that R1 did not receive Clotrimazole 1% topical cream for their evening dose (5:00pm) on July 18, 2024 and did not receive 5 medications for their bedtime dose (8:00pm), Ciclopirox 8% solution, Lisinopril 20 mg, Quetiapine Fumarate 25 mg, Quetiapine Fumarate 50 mg and Rosuvastatin Calcium 5 mg, on July 20, 2024. R1 did not receive 6 medications for their bedtime dose (8:00pm) on September 18, 2024, Ciclopirox 8% solution, Glucerna shake, Lisinopril 20 mg, Quetiapine Fumarate 50 mg, Rosuvastatin Calcium 5 mg and Senna Plus 8.6-50mg. |